✦ LIBER ✦

Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables

✍ Scribed by Woo Chul Noh; Yang Hee Kim; Min Suk Kim; Jae Soo Koh; Hyun-Ah Kim; Nan Mo Moon; Nam-Sun Paik

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 237 KB
Volume: 110
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9746-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of estrogen signaling activat

Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer

✍ Yuan Yao; Angela M. H. Brodie; Nancy E. Davidson; Thomas W. Kensler; Qun Zhou 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 399 KB

Expression of cyclin A in endometrial ad

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

✍ N. Kyushima; J. Watanabe; H. Hata; T. Jobo; T. Kameya; H. Kuramoto 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 218 KB

Reduction of ribosome biogenesis with ac

Reduction of ribosome biogenesis with activation of the mTOR pathway in denervated atrophic muscle

✍ Masanao Machida; Kohei Takeda; Hiroyuki Yokono; Sachiko Ikemune; Yuka Taniguchi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract Mammalian target of rapamycin (mTOR) pathway positively regulates the cell growth through ribosome biogenesis in many cell type. In general, myostatin is understood to repress skeletal muscle hypertrophy through inhibition of mTOR pathway and myogenesis. However, these relationships hav

The Fanconi anemia family of genes and i

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features

✍ E. Barroso; G. Pita; J. I. Arias; P. Menendez; P. Zamora; M. Blanco; J. Benitez; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 152 KB

Activation of the Nrf2–ARE signaling pat

Activation of the Nrf2–ARE signaling pathway: a promising strategy in cancer prevention

✍ Aldo Giudice; Maurizio Montella 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

A major protective mechanism against oxidizing substances capable of damaging DNA integrity and initiating carcinogenesis is the induction of phase II detoxification and antioxidant enzymes by chemopreventive agents. A key finding in the field of chemoprevention has been the discovery that the induc

PI3K pathway activation in breast cancer

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

✍ Elena López-Knowles; Sandra A. O'Toole; Catriona M. McNeil; Ewan K.A. Millar; Mi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 552 KB

## Abstract Breast cancer is a common malignancy with current biological therapies tailored to steroid hormone (ER, PR) and HER2 receptor status. Understanding the biological basis of resistance to current targeted therapies and the identification of new potential therapeutic targets is an ongoing